International Journal of Radiation Oncology * Biology * Physics
Volume 66, Issue 5 , Pages 1320-1327 , 1 December 2006

Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT)

  • Sunanda Pejavar, M.D.

      Affiliations

    • Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT
  • ,
  • Lynn D. Wilson, M.D., M.P.H.

      Affiliations

    • Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT
  • ,
  • Bruce G. Haffty, M.D.

      Affiliations

    • Department of Radiation Oncology, UMDNJ-Robert Wood Johnson Medical School and Cancer Institute of New Jersey, New Brunswick, NJ
    • Corresponding Author InformationReprint requests to: Bruce G. Haffty, M.D., Robert Wood Johnson Medical School-UMDNJ, Cancer Institute of New Jersey, 195 Little Albany St., New Brunswick, NJ 08901. Tel: (732) 235-5203; Fax: (732) 235-7493

Received 22 June 2006 ,Revised 22 July 2006 ,Accepted 25 July 2006.

References 

  1. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 1997;79:1918–1922
  2. Fein DA, Fowble BL, Hanlon AL, et al. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol. 1997;65:34–39
  3. McGee JM, Youmans R, Clingan F, et al. The value of axillary dissection in T1a breast cancer. Am J Surg. 1996;172:501
  4. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181–187
  5. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001;25:767–772
  6. Dewar JA, Sarrazin D, Benhamou E, et al. Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1987;13:475–481
  7. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674–681
  8. Fowble B, Solin LJ, Schultz DJ, et al. Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys. 1989;17:703–710
  9. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567–575
  10. Louis-Sylvestre C, Clough K, Asselain B, et al. Axillary treatment in conservative management of operable breast cancer: Dissection or radiotherapy? (Results of a randomized study with 15 years of follow-up). J Clin Oncol. 2004;22:97–101
  11. Wazer DE, Erban JK, Robert NJ, et al. Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer. 1994;74:878–883
  12. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. J Natl Cancer Inst. 2006;98:599–609
  13. National Cancer Institute. National Cancer Institute Clinical Trials Database. Available at http://www/nci.nci.gov/clinicaltrials/.
  14. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. J Clin Oncol. 2005;23:7703–7720
  15. Halverson KJ, Taylor ME, Perez CA, et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 1993;26:593–599
  16. Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 1991;9:988–996
  17. Haffty BG, McKhann C, Beinfield M, et al. Breast conservation therapy without axillary dissection (A rational treatment strategy in selected patients). Arch Surg. 1993;128:1315–1319
  18. Chua B, Ung O, Boyages J. Competing considerations in regional nodal treatment for early breast cancer. Breast J. 2002;8:15–22
  19. Dewar JA, Sarrazin D, Benhamou E, et al. Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1987;13:475–481
  20. Fletcher GH. Reflections on breast cancer. Int J Radiat Oncol Biol Phys. 1976;1:769–779
  21. Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000;88:608–614
  22. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–553
  23. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864–1867
  24. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818–1822
  25. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer. 2000;89:574–581
  26. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—A multicenter validation study. N Engl J Med. 1998;339:941–946
  27. Veronesi U, Rilke F, Luini A, et al. Distribution of axillary node metastases by level of invasion. Cancer (Phil). 1987;59:682–687
  28. Galper S, Recht A, Silver B, et al. Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? (Implications for treatment after a positive sentinel node biopsy). Int J Radiat Oncol Biol Phys. 2000;48:125–132
  29. Schlembach PJ, Buchholz TA, Ross MI, et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2001;51:671–678
  30. Fowble B, Schultz D, Overmoyer B, et al. The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys. 1994;30:23–69
  31. Grills IS, Kestin LL, Goldstein N, et al. Risk factors for regional nodal failure after breast-conserving therapy: Regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys. 2003;56:658–670
  32. Renolleau C, Merviel P, Clough KB, et al. Isolated axillary recurrences after conservative treatment of breast cancer. Eur J Cancer. 1996;32A:617–621
  33. Harris EER, Hwang WT, Seyednejad F, et al. Prognosis after regional lymph node recurrence in patients with stage I–II breast carcinoma treated with breast conservation therapy. Cancer. 2003;98:2144–2151

PII: S0360-3016(06)02748-9

doi: 10.1016/j.ijrobp.2006.07.1379

International Journal of Radiation Oncology * Biology * Physics
Volume 66, Issue 5 , Pages 1320-1327 , 1 December 2006